TIME TO LOSS OF EFFICACY FOLLOWING TOFACITINIB INTERRUPTION IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM OCTAVE SUSTAIN

Marla C. Dubinsky  1     Kofi Clarke  2     Jochen G. Klaus  3     Yoram Bouhnik  4     Arif Soonasra  5     Andrew J. Thorpe     Haiying Zhang     Gary S. Friedman     Deborah A. Woodworth     Nervin Lawendy     Chinyu Su    
1 Icahn School of Medicine, Mount Sinai,New York, NY,United States
2 Division of Gastroenterology and Hepatology, Penn State College of Medicine,Hershey, PA,United States
3 Department of Medicine, Universitätsklinikum Ulm,Ulm,Germany
4 Gastroentérologie, MICI et Assistance Nutritive, Hôpital Beaujon,Clichy,France
5 Pfizer Inc,Collegeville, P

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing